1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with solid tumors. (10th December 2020) Authors: Aroldi, Francesca; Sacco, Joseph; Harrington, Kevin; Olsson-Brown, Anna; Nanclares, Pablo; Menezes, Lavita; Bommareddy, Praveen; Thomas, Suzanne; Kaufman, Howard; Samakoglu, Selda; Coffin, Robert; Middleton, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts. (9th November 2020) Authors: Middleton, Mark; Aroldi, Francesca; Sacco, Joseph; Milhem, Mohammed; Curti, Brendan; MBioeth, Ari VanderWalde; Baum, Scott; Samson, Adel; Pavlick, Anna; Chesney, Jason; Niu, Jiaxin; Rhodes, Terence; Bowles, Tawnya; Conry, Robert; Olsson-Brown, Anna; Laux, Douglas Earl; Kaufman, Howard; Bommareddy... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer. (10th December 2020) Authors: Bortone, Dante; Vensko, Steven; Entwistle, Sarah; Cogdill, Alexandria; Monette, Anne; Najjar, Yana; Sweis, Randy; Tschernia, Nicholas; Wennerberg, Erik; Bommareddy, Praveen; Haymaker, Cara; Khan, Uqba; McGee, Heather; Park, Wungki; Sater, Houssein; Spencer, Christine; Ascierto, Maria; Barsan, Val... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P854 Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets. (15th April 2020) Authors: Rudqvist, Nils-Petter; Zappasodi, Roberta; Wells, Daniel; Thorsson, Vésteinn; Cogdill, Alexandria; Monette, Anne; Najjar, Yana; Sweis, Randy; Wennerberg, Erik; Bommareddy, Praveen; Haymaker, Cara; Khan, Uqba; McGee, Heather; Park, Wungki; Sater, Houssein Abdul; Spencer, Christine; Tschernia, Nich... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 1 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗